The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review.

ABSTRACT:

Background

The global prevalence of non-alcoholic steatohepatitis (NASH) is increasing, such that NASH is predicted to become the leading cause of liver transplantation (LT) in the US by 2025. Despite this, data on the economic burden of NASH are limited.

Objectives

This systematic literature review aimed to summarise and critically evaluate studies reporting on the economic burden of NASH and identify evidence gaps for subsequent research.

Methods

Medline, EMBASE, the Cochrane Library and EconLit were searched up to 6 January 2021 for English language articles published from January 2010 to January 2021 inclusive that reported economic outcomes of a NASH population or subpopulation. Evidence was presented and synthesised using narrative data analysis, and quality was

SUBMITTER: Witkowski M 

PROVIDER: S-EPMC9300564 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature